# US 2012/0255042 A1 · Method of regulating gene expression

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0255042 A1
- Document ID: US20120255042A1
- Status: Published application
- Kind: A1
- Application number: 13/356,514
- Filed: 2012-01-23
- Published: 2012-10-04
- Earliest claimed: 2002-05-03
- Assignees: Duke University
- Inventors: Bryan R. CULLEN; Yan ZENG
- Web page: https://patentgrep.com/patent/US20120255042A1

## CPC

- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C12N 15/8218: {Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]}
- C12N 15/8241: {Phenotypically and genetically modified plants via recombinant DNA technology}
- C12N 2310/111: spanning the whole gene, or a large part of it
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/53: partially self-complementary or closed
- C12N 2310/531: Stem-loop; Hairpin
- C12N 2330/30: chemically synthesised
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The present invention relates, in general, to gene expression and, in particular, to a method of inhibiting the expression of a target gene and to constructs suitable for use in such a method.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A method of inhibiting expression of a target gene comprising introducing into an isolated human or non-human animal cell a DNA construct comprising a constitutive or inducible promoter operably linked to a nucleic acid comprising a sequence encoding a naturally occurring microRNA (miRNA) precursor, wherein a portion of the stem of the stem loop structure of said miRNA precursor is complementary to a portion of an RNA transcript of said gene,
wherein, following introduction of said construct into said cell:
i) said nucleic acid is transcribed so that a transcript comprising said miRNA precursor is produced,
ii) said transcript resulting from step (i) is processed so that said miRNA precursor is excised therefrom,
iii) said miRNA precursor resulting from step (ii) is processed so that a mature miRNA about 21 or 22 nucleotides in length is excised from said miRNA precursor, and
iv) inhibition of expression of said gene is effected.

### Claim 32 (depends on 31)

The method according to claim 31 wherein said miRNA precursor is a miR-30 precursor.

### Claim 33 (depends on 31)

The method according to claim 31 wherein said miRNA precursor is a miR-21 precursor.

### Claim 34 (depends on 31)

The method according to claim 31 wherein said promoter is a polymerase II-based promoter.

### Claim 35 (depends on 31)

The method according to claim 31 wherein said promoter is a tissue specific promoter.

### Claim 36 (depends on 31)

The method according to claim 31 wherein said promoter is an inducible promoter.

### Claim 37 (depends on 31)

The method according to claim 31 wherein said nucleic acid comprises a sequence encoding more than one naturally occurring miRNA precursor.

### Claim 38 (depends on 31)

The method according to claim 31 wherein said construct is present in a viral vector or plasmid.

### Claim 39 (depends on 38)

The method according to claim 38 wherein said construct is present in a lentiviral vector.

### Claim 40 (depends on 31)

The method according to claim 31 wherein said gene is a cellular gene, a transgene or a pathogen gene.
